IRIS Accounts Production v24.3.2.46 02846145 Board of Directors Board of Directors 1.3.24 28.2.25 28.2.25 false true false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh028461452024-02-29028461452025-02-28028461452024-03-012025-02-28028461452023-02-28028461452023-03-012024-02-29028461452024-02-2902846145ns15:EnglandWales2024-03-012025-02-2802846145ns14:PoundSterling2024-03-012025-02-2802846145ns10:Director12024-03-012025-02-2802846145ns10:Director22024-03-012025-02-2802846145ns10:PrivateLimitedCompanyLtd2024-03-012025-02-2802846145ns10:SmallEntities2024-03-012025-02-2802846145ns10:AuditExempt-NoAccountantsReport2024-03-012025-02-2802846145ns10:SmallCompaniesRegimeForDirectorsReport2024-03-012025-02-2802846145ns10:SmallCompaniesRegimeForAccounts2024-03-012025-02-2802846145ns10:FullAccounts2024-03-012025-02-2802846145ns10:RegisteredOffice2024-03-012025-02-2802846145ns5:CurrentFinancialInstruments2025-02-2802846145ns5:CurrentFinancialInstruments2024-02-2902846145ns5:ShareCapital2025-02-2802846145ns5:ShareCapital2024-02-2902846145ns5:RevaluationReserve2025-02-2802846145ns5:RevaluationReserve2024-02-2902846145ns5:RetainedEarningsAccumulatedLosses2025-02-2802846145ns5:RetainedEarningsAccumulatedLosses2024-02-2902846145ns5:PlantMachinery2024-03-012025-02-2802846145ns5:FurnitureFittings2024-03-012025-02-2802846145ns5:MotorVehicles2024-03-012025-02-2802846145ns5:ComputerEquipment2024-03-012025-02-2802846145ns5:PlantMachinery2024-02-2902846145ns5:FurnitureFittings2024-02-2902846145ns5:MotorVehicles2024-02-2902846145ns5:ComputerEquipment2024-02-2902846145ns5:PlantMachinery2025-02-2802846145ns5:FurnitureFittings2025-02-2802846145ns5:MotorVehicles2025-02-2802846145ns5:ComputerEquipment2025-02-2802846145ns5:PlantMachinery2024-02-2902846145ns5:FurnitureFittings2024-02-2902846145ns5:MotorVehicles2024-02-2902846145ns5:ComputerEquipment2024-02-2902846145ns5:WithinOneYearns5:CurrentFinancialInstruments2025-02-2802846145ns5:WithinOneYearns5:CurrentFinancialInstruments2024-02-2902846145ns5:RevaluationReserve2024-02-29
REGISTERED NUMBER: 02846145 (England and Wales)














Financial Statements for the Year Ended 28 February 2025

for

Excel Health Care Limited

Excel Health Care Limited (Registered number: 02846145)






Contents of the Financial Statements
for the Year Ended 28 February 2025




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


Excel Health Care Limited

Company Information
for the Year Ended 28 February 2025







DIRECTORS: Mr P E Andrews
Mrs A G Andrews





REGISTERED OFFICE: Unit 5 Childerditch Industrial Park
Childerditch Hall Drive
Little Warley
Brentwood
Essex
CM13 3HD





REGISTERED NUMBER: 02846145 (England and Wales)





ACCOUNTANTS: Nordens
The Retreat
406 Roding Lane South
Woodford Green
Essex
IG8 8EY

Excel Health Care Limited (Registered number: 02846145)

Statement of Financial Position
28 February 2025

28.2.25 29.2.24
Notes £    £    £    £   
FIXED ASSETS
Property, plant and equipment 4 291,874 488,062
Investment property 5 588,000 560,000
879,874 1,048,062

CURRENT ASSETS
Inventories 503,013 717,829
Debtors 6 2,390,020 2,175,280
Cash at bank 824,780 667,368
3,717,813 3,560,477
CREDITORS
Amounts falling due within one year 7 1,657,799 1,523,141
NET CURRENT ASSETS 2,060,014 2,037,336
TOTAL ASSETS LESS CURRENT LIABILITIES 2,939,888 3,085,398

PROVISIONS FOR LIABILITIES 43,063 309,641
NET ASSETS 2,896,825 2,775,757

CAPITAL AND RESERVES
Called up share capital 2 2
Revaluation reserve 8 107,801 86,801
Retained earnings 2,789,022 2,688,954
SHAREHOLDERS' FUNDS 2,896,825 2,775,757

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Excel Health Care Limited (Registered number: 02846145)

Statement of Financial Position - continued
28 February 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 3 April 2025 and were signed on its behalf by:




Mr P E Andrews - Director



Mrs A G Andrews - Director


Excel Health Care Limited (Registered number: 02846145)

Notes to the Financial Statements
for the Year Ended 28 February 2025

1. STATUTORY INFORMATION

Excel Health Care Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 15% on reducing balance
Fixtures and fittings - 15% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 25% on reducing balance

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Stocks
Inventories are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Excel Health Care Limited (Registered number: 02846145)

Notes to the Financial Statements - continued
for the Year Ended 28 February 2025

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 17 (2024 - 23 ) .

4. PROPERTY, PLANT AND EQUIPMENT
Fixtures
Plant and and Motor Computer
machinery fittings vehicles equipment Totals
£    £    £    £    £   
COST
At 1 March 2024 1,054,053 13,056 15,000 21,912 1,104,021
Additions 194,908 - - - 194,908
Disposals (425,211 ) - - - (425,211 )
At 28 February 2025 823,750 13,056 15,000 21,912 873,718
DEPRECIATION
At 1 March 2024 589,172 4,847 11,440 10,500 615,959
Charge for year 123,563 1,272 890 4,238 129,963
Eliminated on disposal (164,078 ) - - - (164,078 )
At 28 February 2025 548,657 6,119 12,330 14,738 581,844
NET BOOK VALUE
At 28 February 2025 275,093 6,937 2,670 7,174 291,874
At 29 February 2024 464,881 8,209 3,560 11,412 488,062

5. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 March 2024 560,000
Revaluations 28,000
At 28 February 2025 588,000
NET BOOK VALUE
At 28 February 2025 588,000
At 29 February 2024 560,000

Excel Health Care Limited (Registered number: 02846145)

Notes to the Financial Statements - continued
for the Year Ended 28 February 2025

5. INVESTMENT PROPERTY - continued

The investment property, Galleon Road was valued £267,000 on an open market basis on 28/02/2025.

The investment property, Batchelor Court was valued £321,000 on an open market basis on 28/02/2025.

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
28.2.25 29.2.24
£    £   
Trade debtors 2,390,020 2,175,280

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
28.2.25 29.2.24
£    £   
Bank loans and overdrafts 25 -
Trade creditors 35,304 -
Taxation and social security 230,745 108,521
Other creditors 1,391,725 1,414,620
1,657,799 1,523,141

8. RESERVES
Revaluation
reserve
£   
At 1 March 2024 86,801
Non distributable reserves 21,000

At 28 February 2025 107,801

9. RELATED PARTY DISCLOSURES

The Directors Mr P Andrew and Mrs P Andrew are considered to be key management personal.